GL1X · GenesisL1 explorer

Research workbench

Human aldose reductase complexed with inhibitor zopolrestat after six days soaking.

Analyse Human aldose reductase complexed with inhibitor zopolrestat after six days… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2FZ9
Type
protein
Length
315 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aldose reductase
EC
1.1.1.21
UniProt
P15121
Ligands
NAP, ZST
Pockets
1 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAldose reductase (EC 1.1.1.21)protein31539% helix, 15% strandP15121

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • ZST · 3,4-dihydro-4-oxo-3-((5-trifluoromethyl-2-benzothiazolyl)methyl)-1-phthalazine acetic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13190.740.8648NAP, ZST

Compared structures

  • 2FZ9 · Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking. · the same entry in another collection · chain A against A, TM-score 1.00
  • P15121 · AlphaFold monomer V2.0 prediction for aldo-keto reductase family 1 member B1 (P15121) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.